ABSTRACT: Tyrosine kinase (TK), vascular endothelial growth factor (VEGF), and matrix metalloproteinases (MMP) are important cancer therapeutic target proteins. Based on reported anti-cancer and cytotoxic activities of Caesalpinia bonduc, this study isolated phytochemicals from young twigs and leaves of C bonduc and identified the interaction between them and cancer target proteins (TK, VEGF, and MMP) in silico. AutoDock Vina, iGEMDOCK, and analysis of pharmacokinetic and pharmacodynamic properties of the isolated bioactives as therapeutic molecules were performed. Seven phytochemicals (7-hydroxy-4′-methoxy-3,11-dehydrohomoisoflavanone, 4,4′-dihydroxy-2'-methoxychalcone, 7,4′-dihydroxy-3,11-dehydrohomoisoflavanone, luteolin, quercetin-3-methyl, kaempferol-3-O-β-d-xylopyranoside and kaempferol-3-O-α-l-rhamnopyranosyl-(1 → 2)-β-D-xylopyranoside) were isolated. Molecular docking analysis showed that the phytochemicals displayed strong interactions with the proteins compared with their respective drug inhibitors. Pharmacokinetic and pharmacodynamic properties of the compounds were promising suggesting that they can be developed as putative lead compounds for developing new anti-cancer drugs.
Introduction
Cancer is one of the non-communicable diseases that pose a great risk to public health and tough challenge to modern medicine. It is a major cause of reported human deaths worldwide with approximately 9 million deaths and more than 14 million new cases reported each year. 1 Deep understanding of the mechanisms of formation and spread of tumour cells is important in the development of new and effective therapeutic agents to induce apoptosis. Apoptosis is a physiological process of cell death, which is well-regulated; thus, cellular inflammatory responses are not induced, making it a safer and better feature of a therapeutic candidate. 2 Some techniques such as chemotherapy, radiation, checkpoint inhibitors, 3 anti-cancer antibodies, 4 and adoptive cell therapies 5 have been developed to induce apoptosis. Inhibition of angiogenesis, tumour vascularization, and tyrosine kinase (TK) activity are key therapeutic points that prevent metastasis and cause apoptosis. 1 Thus, TK, vascular endothelial growth factor (VEGF), and matrix metalloproteinases (MMP) are important therapeutic targets. Natural products, medicinal plants, and plant-based food have played an important role in management, treatment, and prevention of cancer. 6 Plants are exceptional and dependable sources of novel anti-cancer therapeutics responsible for more than 60% of the various anti-cancer agents available. 7 Caesalpinia bonduc (Linn) Roxb., commonly known as Gray Nicker nut and Ayo by the Yoruba tribe in south-west Nigeria, is a prickly shrub with a hard, grey, globular-shaped, and smooth shining surface seeds found in tropical and subtropical Africa, Asia, and the Caribbean. 8 Glycosides, alkaloids, and cassane/voucapane diterpenoids in seed kernel; cassane diterpene, caesaldekarins (-F, -G, and -C), caesalpinin, and bonducellpins (-A, -B, -C, and -D) in roots; homoisoflavonoids, 6-o-methylcaesalpinianone, and caesalpinianone in bark; and pinitol, brazillin, and bonducin in leaves are various bioactive phytoconstituents that have been identified. 9, 10 Isolated flavonoids from C bonduc have been reported to have exhibit antiplasmodial and anti-cancer activities against chloroquine sensitive strain of Plasmodium falciparum (FCR-3) 8 and HeLa 11 cells, respectively. Anti-cancer and cytotoxic activities of various parts of C bonduc 7, 10, 11, 12 as well as its isolated phytoconstituents 13, 14 have been reported, with upregulation of Bax and activation of poly (ADP-ribose) polymerase (PARP) as a possible mechanism of apoptosis induction. Despite these broad studies, there is a dearth of information on the molecular interaction between the phytoconstituents and proteins involved in angiogenesis, metastasis, and apoptosis. This study, therefore, investigates the molecular interaction of identified phytochemicals present in young twigs and leaves of C bonduc with human VEGF, TK, and MMP as well as their absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties in silico.
Extraction and solvent fractionation of plant material
The leaves and young twigs of the plant collected were air dried at room temperature and powdered. Powdered plant (8.8 kg) was extracted with 75% v/v ethanol (50 L) at normal room temperature (25 o C) by maceration for 72 hours using 3 consecutive extractions. The total filtrate was concentrated to dryness with rotary evaporator at 50 o C. The dried ethanolic extract of the plant (1120 g) was re-suspended in distilled water (H 2 O) and partitioned in sequence with petroleum ether, ethyl acetate, and n-butanol. The different solvent fractions were concentrated with rotary evaporator to yield petroleum ether -soluble fraction (150 g), ethyl acetate -soluble fraction (120 g), n-butanol -soluble fraction (170 g), and H 2 O -soluble fraction (630 g).
Fractionation, isolation, and identification of compounds
Ethyl acetate and petroleum ether soluble fractions were combined (270 g) and separated by column chromatography (CC; 3 kg silica gel, mesh 100-200; solvent: chloroform-methanol [100 :1] 
Ligand modeling
The structures (.sd) of the identified compounds were sketched using ChemDraw and used as ligands. 15 The SD files were converted to their corresponding three-dimensional (3D) structures and saved as .pdb format using Open Babel. 16 Gasteiger charges were added and non-polar hydrogens were merged using AutoDock4.2. 17 
In silico analysis of drug-likeness
The drug-likeness of the screened compounds was calculated using SwissADME. 18 The ligands were subjected to Lipinski, 19 Ghose, 20 Veber, 21 Egan, 22 and Muegge 23 screening. Only ligands that were able to satisfy these variants without default were used for docking simulation.
Protein preparation
The 3D crystal structures of human VEGF, human TK, and human MMP were retrieved from Research Collaboratory for Structural Bioinformatics (RCSB) protein data bank (PDB) as 1vpf, 1fku, and 2oxu as their respective PDB codes without any complexed ligands. The protein structures were cleaned, water molecules removed, Gasteiger charges computed, polar hydrogens added, and non-polar hydrogens merged using AutoDock4.2. 17 
Active site prediction
The possible active binding sites of the proteins were obtained using DoGSiteScorer. 24 The binding sites with the best volume, surface area, and druggability score were selected for this study. DoGSiteScorer is a grid-based method, which uses a difference of Gaussian filter to detect potential binding pockets, solely based on the 3D structure of the protein, and splits them into subpockets.
Docking simulations
AutoDock4.2 was used to transform both receptor and ligand structures to pdbqt file format, which includes atomic charges, atom-type definitions and, for ligands, topological information (rotatable bonds) with a grid centred to ensure coverage of the binding site of the structure. AutoDock Vina was used to perform docking simulations, generating 9 conformations of ligand in complex with the receptor, which were finally ranked 3 on the basis of binding energy. 25 Target proteins and ligands were docked with iGEMDOCK (version 2.1). The genetic algorithm (GA) parameters, which guided the docking procedure, were set as 200 (population size), 70 (generations), and 3 (number of solution). Bond energies, such as hydrogen bond (Hb), van der Waals (VdW), and electrostatic interaction that occurred between the proteins and ligands were identified. The resulting conformations were visualized in the Discovery Studio Visualizer 26 and PyMol. 27 
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ADMET properties
The in silico ADMET properties of the selected compounds were calculated as an alternative approach to the expensive experimental evaluation of ADMET profiles. 28 For ADMET assessment, we used admetSAR32 to examine the different pharmacokinetic parameters of the docked ligands. Figure 1 illustrates the 7 flavonoids (7-hydroxy-4′-methoxy-3,11-dehydrohomoisoflavanone; 4,4′-dihydroxy-2'-methoxychalcone; 7,4'-dihydroxy-3,11-dehydrohomoisoflavanone; luteolin; quercetin-3-methyl; kaempferol-3-O-β-D-xylopyranoside; and kaempferol-3-O-α-L-rhamnopyranosyl-(1→2)-β-D-xylopyranoside) that were isolated via bioassay-guided fractionation of both the petroleum ether and ethyl acetate fractions of C bonduc ethanolic extract. These compounds have previously been isolated from different parts of Caesalpinia spp., Draba nemorosa and Bauhinia racemosa. 29, 30, 31, 32 
Results and Discussion
Fractionation, isolation, and identification results
Drug-likeness results
In estimating drug-likeness of a compound, the compliance of the compounds' physicochemical properties with filter variants such as Lipinski rule of 5 (RO5), Ghose filter, Veber rule, Egan rule, and Muegge rule is paid close attention. Properties such as the number of hydrogen bond donors (HBD), hydrogen bond acceptors (HBA), molecular mass, logP, molar refractivity, rotatable bonds, topological polar surface area (TPSA), and number of rotatable bonds are taken into consideration. 20, 21, 22, 23, 33 Among these isolated phytochemicals, only 7-hydroxy-4′-methoxy-3,11-dehydrohomoisoflavanone; 4,4′-dihydroxy-2′-methoxy-chalcone; 7,4′-dihydroxy-3,11-dehydrohomoisoflavanone; luteolin; and quercetin-3-methyl passed all the various drug-likeness tests they were subjected to without any default. Kaempferol-3-O-β-D-xylopyranoside and kaempferol-3-O-α-L-rhamnopyranosyl-(1 → 2)-β-Dxylopyranoside had defaults in all variants except for Ghose test of drug-likeness which kaempferol-3-O-β-Dxylopyranoside passed (Table 1) . Lead compounds whose properties successfully pass these variants are considered to 
Bioinformatics and Biology Insights abbreviations: hb-ir, hydrogen bonds interacting residues; MMP, matrix metalloproteinases; Pi-ir, Pi bonds interacting residues; Tk, tyrosine kinase; vdW-ir, van der Waals interacting residues; vEGF, vascular endothelial growth factor.
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possess good pharmacokinetic properties and thus are further subjected to various in silico techniques such as molecular docking. 34 Out of the 7 isolated compounds, 5 passed all the filter variants without any default and thus could be considered as lead compounds with good pharmacokinetic properties.
Docking simulations results
Molecular docking is an important in silico technique, which predicts the mode of interaction between a small ligand and target protein for an established binding site. 35 Binding energy informs us on the strength and how much affinity a compound binds to the pocket of a target protein (as shown in Figure 2) . A compound with a lower binding energy is preferred as a possible drug candidate and vice versa. 36, 37 Vina uses a sophisticated gradient optimization method in its local optimization procedure 25 while iGEMDOCK uses an empirical scoring function and an evolutionary approach. 38 Table 3 ). Hydrogen, van der Waal, and various pi bonds stabilizing interactions were present between the ligands and amino acid residues present in the active site of the proteins. Arg 160 and Asn 397 were amino acid residues in the pockets responsible for the binding of all ligands to TK, while Ala182, Lys 233, and 241 were responsible for ligand binding to MMP (Figures 6, 7 and 8 ). Despite the differences in the scoring algorithm of both AutoDock Vina and iGEMDOCK, the predicted stronger binding affinity of the isolated compounds to MMP binding pocket than batimastat is predictive of a better Ki value qualifying them as hit inhibitors of MMP The 2D and 3D views of (a) 7-hydroxy-4′-methoxy-3,11-dehydrohomoisoflavanone, (B) 4,4′-dihydroxy-2′-methoxy-chalcone, (C) 7,4′-dihydroxy-3,11-dehydrohomoisoflavanone, (D) luteolin, (E) quercetin-3-methyl, and (F) pazopanib interactions with vEGF using autoDock vina. In each case, the hydrogen, pi-donor hydrogen, pi-alkyl, pi-sigma, and pi-anion bond interactions are shown as green, light blue, magenta, purple, and orange broken lines, respectively, while ligand backbones are green. 2D indicates two-dimensional; 3D, three-dimensional; vEGF, vascular endothelial growth factor.
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(Continued) Figure 4 . The 2D and 3D views of (a) 7-hydroxy-4′-methoxy-3,11-dehydrohomoisoflavanone, (B) 4,4′-dihydroxy-2′-methoxy-chalcone, (C) 7,4′-dihydroxy-3,11-dehydrohomoisoflavanone, (D) luteolin, (E) quercetin-3-methyl, and (F) imatinib interactions with Tk using autoDock vina. In each case, the hydrogen, pi-donor hydrogen, pi-alkyl, pi-sigma, pi-pi, and pi-anion bond interactions are shown as green, light blue, magenta, purple, indigo, and orange broken lines, respectively, while ligand backbones are represented in green. 2D indicates two-dimensional; 3D, three-dimensional; Tk, tyrosine kinase. and potential leads against cancer. 39, 40 Several amino acid residues present in the binding pocket of proteins are involved in the various interactions that occur between ligand and their targets. These residues are ligand-dependent as the isolated phytochemicals bind to different residues within the binding pocket. However, Lys 241 was involved in stabilizing MMPligand interactions in both AutoDock Vina and iGEM-DOCK. This amino acid residue is somewhat amphipathic with a long hydrophobic carbon tail close to the backbone and a positively charged amino group on the side chain. It is frequently found in the binding sites of proteins where they form hydrogen bonds with ligands and also function in acid-base catalysis, 41, 42 making it a viable drug target. 43 
ADMET results
In the preliminary stages of the drug discovery process, it is important to measure various indices of absorption, distribution, metabolism, excretion, and toxicology (ADMET). 44 It is a key and considerable step, which eliminates lead compounds with the ability to elicit hazardous side effects. 43 Laboratory experimentation of ADMET is very expensive and time consuming, making in silico ADMET evaluation a much viable option, thereby preventing potential drug failures during clinical trials. 45 The docked ligands as illustrated in Table 4 , showed no inhibitory side effects on renal organic cation transport. Positive results were observed for human intestinal absorption (HIA), Caco-2 permeability (CP), and blood-brain barrier (BBB) penetrability. However, 7-hydroxy-4′-methoxy-3,11-dehydrohomoisoflavanone, quercetin-3-methyl, and 7,4′-dihydroxy-3,11-dehydrohomoisoflavanone exhibited negative results for BBB. When a drug is administered orally, absorption occurs primarily in the intestine. Transporter proteins, efflux proteins, and phase II conjugation enzymes are highly expressed by Caco-2 cells, which make them useful models of transcellular pathways and metabolic biotransformation of test. 34, 46 The compounds exhibited positive results to both HIA and CP, indicating that these compounds could be absorbed or assimilated through human intestine. Compounds that exhibited positive results for BBB might also have pharmacological brain function. Luteolin being the exception, all other compounds were P-glycoprotein (P-gp) substrates. Nevertheless, none of the ligands were identified as P-gp non inhibitors (Table 4 ). In metabolism, no ligand was a substrate for all cytochrome isoforms (2C9, 2D6, and 3A4). On the contrary, they all exhibited high cytochrome P450 inhibitory promiscuity (CYP IP). Despite inhibiting isoforms 1A2, 2C9, and 2C19, the isolated compounds are not inhibitors of isoform 2D6 (Table 5) . Cytochrome P450 enzymes are responsible for the metabolism and clearance of drugs and xenobiotics from biological systems. Five isoforms (1A2, 2C9, 2C19, 2D6, and 3A4) predominantly expressed in the liver and also in the small intestine, lungs, placenta, and kidneys important in xenobiotic metabolism. 47 When any isoform of CYP is inhibited, malfunctioning of drug metabolism and elevation of toxicity is always a usual occurrence. 48 The inhibition of 1A2, 2C9, and 2C19 CYP isoforms by the compounds suggests that the phytochemicals may affect drug metabolism; thus, the dosage concentration should be a critical factor to consider during drug design of these lead compounds. The safety of the compounds is absolutely crucial for a successful drug. A drug like a candidate should meet certain ADMET parameters, which is as critical as therapeutic properties. 34 The isolated phytochemicals were weak inhibitors of human 9 Figure 5 . The 2D and 3D views of (a) 7-hydroxy-4′-methoxy-3,11-dehydrohomoisoflavanone, (B) 4,4′-dihydroxy-2′-methoxy-chalcone, (C) 7,4′-dihydroxy-3,11-dehydrohomoisoflavanone, (D) luteolin, (E) quercetin-3-methyl, and (F) batimastat interactions with MMP using autoDock vina. In each case, the hydrogen, pi-donor hydrogen, pi-alkyl, pi-sigma, pi-pi, pi-sulphur, and pi-anion bond interactions are shown as green, light blue, magenta, purple, indigo, golden brown, and orange broken lines, respectively, while ligand backbones are represented in green. MMP indicates matrix metalloproteinases; 2D, two-dimensional; 3D, three-dimensional. 
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11 Figure 6 . The 2D and 3D views of (a) 7-hydroxy-4′-methoxy-3,11-dehydrohomoisoflavanone, (B) 4,4′-dihydroxy-2′-methoxy-chalcone, (C) 7,4′-dihydroxy-3,11-dehydrohomoisoflavanone, (D) luteolin, (E) quercetin-3-methyl, and (F) pazopanib interactions with vEGF using iGEMDOCk. In each case, the hydrogen, pi-donor hydrogen, pi-alkyl, amide pi-stacked, pi-sulphur, pi-lone pair, and pi-cation bond interactions are shown as green, light blue, magenta, purple, indigo, golden brown, light green, and orange broken lines, respectively, while ligand backbones are represented in green. 2D indicates twodimensional; 3D, three-dimensional; vEGF, vascular endothelial growth factor. Figure 7 . The 2D and 3D views of (a) 7-hydroxy-4′-methoxy-3,11-dehydrohomoisoflavanone, (B) 4,4′-dihydroxy-2′-methoxy-chalcone, (C) 7,4′-dihydroxy-3,11-dehydrohomoisoflavanone, (D) luteolin, (E) quercetin-3-methyl, and (F) imatinib interactions with Tk using iGEMDOCk. In each case, the hydrogen, pi-donor hydrogen, pi-alkyl, pi-sigma, pi-pi stacked, and pi-cation bond interactions are shown as green, light blue, magenta, purple, indigo, and orange broken lines, respectively, while ligand backbones are represented in green. 2D indicates two-dimensional; 3D, three-dimensional; Tk, tyrosine kinase.
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Figure 8. The 2D and 3D views of (a) 7-hydroxy-4′-methoxy-3,11-dehydrohomoisoflavanone, (B) 4,4′-dihydroxy-2′-methoxy-chalcone, (C) 7,4′-dihydroxy-3,11-dehydrohomoisoflavanone, (D) luteolin, (E) quercetin-3-methyl, and (F) Batimastat interactions with MMP using iGEMDOCk. In each case, the hydrogen, pi-donor hydrogen, pi-alkyl, pi-sigma, pi-pi stacked, pi-cation, and unfavourable bump bond interactions are shown as green, light blue, magenta, purple, indigo, orange, and red broken lines, respectively, while ligand backbones are represented in green. MMP indicates matrix metalloproteinases; 2D, two-dimensional; 3D, three-dimensional. ether-a-go-go-related genes and exhibit no properties that exert significant toxicity in humans. Only 7-hydroxy-4′-methoxy-3,11-dehydrohomoisoflavanone and 7,4′-dihydroxy-3,11-dehydrohomoisoflavanone were positive for Ames toxicity. In contrast, all of the selected compounds were found to present high toxicity for fish, Tetrahymena pyriformis, and honey bees (Table 6 ). The toxicity profiles of the docked compounds revealed that they were non-mutagenic and carcinogenic.
Conclusions
This study focused on the discovery of potent inhibitors of VEGF, TK, and MMP as a potential therapy for cancer using in silico methods. When compared with already established anti-cancer drugs, the binding energy was highly comparable as well as interactions with the proteins. They also possess good ADMET properties, indicating these phytochemical isolates can also be considered safe and thus be further developed into active commercial anti-cancer drugs. Nevertheless, during lead optimization process, the CYP inhibitory promiscuity of the compounds needs to be improved and Lys 241 amino acid residue can be targeted as a promising mode of action to modulate the activity of MMP. Molecular dynamics simulation as well as molecular mechanics energies combined with the PoissonBoltzmann or generalized Born and surface area continuum solvation (MM-PBSA/GBSA) analyses can be performed to further validate docking results. Further in vitro and in vivo investigations can be performed to further authenticate the physiological relevance of these results.
Author Contributions
FNI and OOO Put up the general concepts and design of the study. FNI and OOO Carried out the implementation of these concepts and design of the work. FNI, OOO, OEO, II and JO Carried out the analysis of the work. FNI Drafted the first manuscript. All authors read and approved the final manuscript.
ORCID iDs
Franklyn Nonso Iheagwam https://orcid.org/0000-0001 -8487-4052 Jelili Oyelade https://orcid.org/0000-0002-5476-4992 Table 6 . Predicted molecular toxicity profile of isolated compounds from Caesalpinia bonduc. abbreviations: aOT, acute oral toxicity; FT, fish toxicity; hBT, honey bee toxicity; hEaggRGI, human ether-a-go-go-related gene inhibition; RaT, rat acute toxicity; TPT, Tetrahymena pyriformis toxicity.
